Ligand Pharmaceuticals (LGND) Q2 2026 Earnings

6MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
1.42
1.98
2.53
3.09

Details

Expected EPS
1.844286
Actual EPS
N/A
Surprise EPS
-1.84
Surprise Percent
+100%

Description

Ligand Pharmaceuticals (LGND) will report earnings of for Q2 2026 on May 06, 2026.

0 Comments

Share your thoughts